What were the most popular posts on Healthcare Economist this year? Here are the top 10 in descending order: Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best PracticesThe world is relying on the United States to get value-based drug pricing rightWhy is the market design for innovative…
In the US, opioid abuse has become and epidemic. However, in the past year, there is some hope that this epidemic is starting to reverse. Opioid deaths have fallen by 16.9% in the past year. Why have deaths fallen? According to The Economist, no one is sure: One possibility is a supply shock…the amount of…
December saw a slew of executive hires, promotions, exits and layoffs across the healthcare industry. For example, companies like Humana and Mayo Clinic hired new C-suite leaders, organizations including Atlantic Health System and Amwell are saying goodbye to key executives, and firms like CVS Health and Optum announced rounds of job cuts. The post Healthcare…
One Phase 3 test of Auvelity met its main goal in Alzheimer’s agitation while the drug’s other pivotal trial showed numerical improvement that fell short of statistical significance. Axsome Therapeutics aims to offer an alternative to Rexulti, a Lundbeck and Otsuka Pharmaceutical product that is the only FDA-approved Alzheimer’s agitation drug. The post Axsome Aims…
The Uno Savings Guide is a free resource that helps people check their eligibility for financial benefit programs, like Medicaid, Medicare Savings Programs and SNAP. The post Uno Health Unveils Tool to Help Americans Check Eligibility for Financial Benefits appeared first on MedCity News.
Opdivo Qvantig, administered by injection in less than five minutes, is now FDA approved for solid tumor indications covered by Opdivo, a 30-minute intravenous infusion. The new product will help Bristol Myers Squibb compete with biosimilars as Opdivo faces looming patent expiration. The post Bristol Myers Squibb Wins FDA Nod for Injectable Version of Blockbuster…
Mimi Winsberg, M.D., discusses study indicating that LLMs can help clinicians triage patients with suicidal ideation
Addressing difficult-to-treat diseases and disorders, quickly, safely, and with little to no side effects is a positive boon to our overburdened health system. The post The Same Processes that Make Smartphones a Risk for Young People Must Be Harnessed to Provide Beneficial Digital Medical Treatments For All appeared first on MedCity News.
While worries about the affordability of care are sure to persist for many Americans over the coming year, here are some other patient payment trends for providers to watch The post 2025 Trends to Watch in Patient Payments appeared first on MedCity News.
In 2024, our nationwide team of gumshoes set out to answer your most pressing questions about medical bills, such as: Can free preventive care really come with add-on bills for items like surgical trays? Or, why does it cost so much to treat a rattlesnake bite? Or, if it’s called an urgent care emergency center,…